 Mamuka Kvaratskhelia
Concepts (415)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Integrase | 39 | 2025 | 74 | 10.020 |
Why?
| | HIV-1 | 48 | 2025 | 908 | 9.330 |
Why?
| | HIV Integrase Inhibitors | 25 | 2024 | 79 | 7.480 |
Why?
| | Virus Integration | 19 | 2025 | 69 | 3.720 |
Why?
| | Drug Resistance, Viral | 6 | 2025 | 126 | 2.590 |
Why?
| | Virus Replication | 14 | 2025 | 521 | 2.570 |
Why?
| | Protein Multimerization | 10 | 2025 | 204 | 2.410 |
Why?
| | Anti-HIV Agents | 7 | 2025 | 912 | 2.310 |
Why?
| | Intercellular Signaling Peptides and Proteins | 11 | 2021 | 376 | 2.310 |
Why?
| | Capsid | 8 | 2025 | 94 | 1.740 |
Why?
| | Capsid Proteins | 7 | 2025 | 94 | 1.690 |
Why?
| | RNA, Viral | 15 | 2025 | 692 | 1.650 |
Why?
| | Protein Binding | 45 | 2025 | 2238 | 1.570 |
Why?
| | DNA, Viral | 11 | 2022 | 356 | 1.550 |
Why?
| | Virion | 7 | 2022 | 108 | 1.420 |
Why?
| | HIV Infections | 19 | 2025 | 3193 | 1.320 |
Why?
| | HEK293 Cells | 23 | 2025 | 741 | 1.240 |
Why?
| | Integrases | 6 | 2017 | 122 | 1.090 |
Why?
| | Virus Assembly | 6 | 2025 | 82 | 1.080 |
Why?
| | Acetamides | 2 | 2025 | 41 | 1.070 |
Why?
| | Indazoles | 2 | 2025 | 85 | 1.060 |
Why?
| | Leukemia Virus, Murine | 4 | 2016 | 17 | 1.030 |
Why?
| | Allosteric Regulation | 13 | 2023 | 99 | 0.960 |
Why?
| | Models, Molecular | 25 | 2025 | 1598 | 0.960 |
Why?
| | Gene Products, gag | 4 | 2018 | 38 | 0.960 |
Why?
| | Retroviridae | 3 | 2025 | 100 | 0.950 |
Why?
| | Mass Spectrometry | 15 | 2017 | 730 | 0.920 |
Why?
| | Antiviral Agents | 6 | 2024 | 769 | 0.890 |
Why?
| | Endodeoxyribonucleases | 8 | 2001 | 77 | 0.880 |
Why?
| | Human T-lymphotropic virus 1 | 7 | 2023 | 32 | 0.860 |
Why?
| | Acetates | 3 | 2014 | 78 | 0.850 |
Why?
| | Nucleosomes | 3 | 2022 | 163 | 0.850 |
Why?
| | Pyrazines | 1 | 2025 | 94 | 0.830 |
Why?
| | HIV Reverse Transcriptase | 7 | 2019 | 31 | 0.820 |
Why?
| | Pyridines | 2 | 2019 | 609 | 0.810 |
Why?
| | Mutation, Missense | 3 | 2014 | 335 | 0.800 |
Why?
| | Nuclear Pore Complex Proteins | 5 | 2025 | 40 | 0.790 |
Why?
| | Prions | 1 | 2022 | 56 | 0.720 |
Why?
| | Genome, Viral | 4 | 2021 | 214 | 0.720 |
Why?
| | Nuclear Proteins | 5 | 2016 | 740 | 0.710 |
Why?
| | HIV Seropositivity | 1 | 2022 | 119 | 0.700 |
Why?
| | Transcription Factors | 7 | 2017 | 1734 | 0.700 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 8 | 2014 | 143 | 0.700 |
Why?
| | Crystallography, X-Ray | 7 | 2025 | 486 | 0.650 |
Why?
| | Protein Conformation | 14 | 2025 | 938 | 0.640 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 85 | 0.630 |
Why?
| | Protein Structure, Tertiary | 14 | 2016 | 855 | 0.550 |
Why?
| | Gene Products, pol | 1 | 2017 | 6 | 0.530 |
Why?
| | Sulfolobus | 7 | 2001 | 11 | 0.530 |
Why?
| | DNA | 13 | 2014 | 1435 | 0.510 |
Why?
| | Quinolines | 3 | 2014 | 190 | 0.500 |
Why?
| | Humans | 67 | 2025 | 145474 | 0.490 |
Why?
| | Protein Interaction Domains and Motifs | 6 | 2019 | 145 | 0.490 |
Why?
| | Archaeal Proteins | 3 | 2001 | 50 | 0.480 |
Why?
| | Binding Sites | 15 | 2021 | 1310 | 0.470 |
Why?
| | Amino Acid Sequence | 19 | 2019 | 2129 | 0.470 |
Why?
| | Recombinant Proteins | 6 | 2013 | 1368 | 0.460 |
Why?
| | Recombination, Genetic | 6 | 2001 | 203 | 0.450 |
Why?
| | Molecular Sequence Data | 19 | 2015 | 2883 | 0.440 |
Why?
| | Protein Footprinting | 6 | 2011 | 11 | 0.430 |
Why?
| | Moloney murine leukemia virus | 1 | 2014 | 13 | 0.430 |
Why?
| | HeLa Cells | 5 | 2020 | 632 | 0.420 |
Why?
| | Transcription Initiation Site | 2 | 2014 | 43 | 0.410 |
Why?
| | Myxovirus Resistance Proteins | 3 | 2025 | 13 | 0.410 |
Why?
| | Viral Proteins | 5 | 2016 | 350 | 0.390 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2015 | 237 | 0.390 |
Why?
| | Nucleic Acid Conformation | 9 | 2021 | 723 | 0.390 |
Why?
| | Cell Line | 12 | 2025 | 2823 | 0.390 |
Why?
| | Cell Cycle Proteins | 6 | 2017 | 630 | 0.380 |
Why?
| | Protein Domains | 5 | 2025 | 311 | 0.370 |
Why?
| | Host-Pathogen Interactions | 5 | 2021 | 361 | 0.370 |
Why?
| | beta Karyopherins | 1 | 2012 | 9 | 0.370 |
Why?
| | Integrase Inhibitors | 1 | 2012 | 1 | 0.360 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2022 | 28 | 0.350 |
Why?
| | Avian Leukosis Virus | 2 | 2017 | 6 | 0.340 |
Why?
| | Archaea | 2 | 2001 | 61 | 0.330 |
Why?
| | RNA, Transfer | 2 | 2016 | 143 | 0.330 |
Why?
| | Mutation | 8 | 2025 | 4075 | 0.320 |
Why?
| | Indoles | 1 | 2014 | 507 | 0.320 |
Why?
| | Catalytic Domain | 8 | 2016 | 234 | 0.310 |
Why?
| | Nuclear Pore | 2 | 2021 | 19 | 0.310 |
Why?
| | Viral Nonstructural Proteins | 3 | 2016 | 63 | 0.300 |
Why?
| | Proteins | 4 | 2020 | 1023 | 0.300 |
Why?
| | Gene Products, tax | 3 | 2019 | 15 | 0.290 |
Why?
| | Peptides | 5 | 2018 | 998 | 0.290 |
Why?
| | DNA Footprinting | 1 | 2008 | 33 | 0.290 |
Why?
| | Structure-Activity Relationship | 5 | 2021 | 563 | 0.270 |
Why?
| | Hepacivirus | 3 | 2016 | 242 | 0.270 |
Why?
| | DNA-Binding Proteins | 9 | 2017 | 1480 | 0.270 |
Why?
| | RNA-Binding Proteins | 4 | 2018 | 447 | 0.270 |
Why?
| | Histones | 3 | 2022 | 666 | 0.260 |
Why?
| | Salicylates | 2 | 2016 | 29 | 0.250 |
Why?
| | Cytoplasm | 2 | 2021 | 254 | 0.250 |
Why?
| | Molecular Dynamics Simulation | 2 | 2020 | 265 | 0.240 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 6 | 2008 | 331 | 0.240 |
Why?
| | Amino Acid Motifs | 4 | 2021 | 219 | 0.240 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2006 | 33 | 0.230 |
Why?
| | Active Transport, Cell Nucleus | 3 | 2025 | 117 | 0.230 |
Why?
| | Holliday Junction Resolvases | 8 | 2001 | 8 | 0.230 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2017 | 43 | 0.230 |
Why?
| | Lysine | 8 | 2022 | 305 | 0.230 |
Why?
| | Cryoelectron Microscopy | 3 | 2025 | 221 | 0.230 |
Why?
| | Ribonuclease H, Human Immunodeficiency Virus | 2 | 2019 | 2 | 0.230 |
Why?
| | DNA Damage | 4 | 2021 | 437 | 0.220 |
Why?
| | Pyridoxal Phosphate | 1 | 2004 | 20 | 0.220 |
Why?
| | Avian Sarcoma Viruses | 1 | 2004 | 4 | 0.220 |
Why?
| | Cyclophilins | 1 | 2025 | 40 | 0.210 |
Why?
| | Aptamers, Nucleotide | 2 | 2018 | 87 | 0.210 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 3 | 2021 | 69 | 0.210 |
Why?
| | Biotin | 2 | 2005 | 32 | 0.200 |
Why?
| | Y-Box-Binding Protein 1 | 1 | 2023 | 5 | 0.200 |
Why?
| | Viral Envelope Proteins | 1 | 2004 | 98 | 0.200 |
Why?
| | Protein Processing, Post-Translational | 3 | 2017 | 471 | 0.200 |
Why?
| | Magnesium | 3 | 2000 | 156 | 0.190 |
Why?
| | Receptors, Virus | 2 | 2019 | 95 | 0.190 |
Why?
| | Chromatography, Gel | 4 | 2009 | 130 | 0.190 |
Why?
| | RNA, Transfer, Lys | 1 | 2002 | 3 | 0.190 |
Why?
| | Molecular Chaperones | 1 | 2025 | 199 | 0.190 |
Why?
| | Cell Nucleus | 2 | 2021 | 588 | 0.190 |
Why?
| | Succinimides | 1 | 2002 | 21 | 0.190 |
Why?
| | Protein Structure, Quaternary | 4 | 2008 | 116 | 0.190 |
Why?
| | Mutagenesis, Site-Directed | 6 | 2009 | 376 | 0.190 |
Why?
| | Xeroderma Pigmentosum Group A Protein | 2 | 2014 | 4 | 0.190 |
Why?
| | Molecular Docking Simulation | 3 | 2019 | 119 | 0.180 |
Why?
| | Chromosomes, Human | 1 | 2022 | 44 | 0.180 |
Why?
| | Drugs, Investigational | 1 | 2022 | 31 | 0.180 |
Why?
| | Thiophenes | 2 | 2016 | 117 | 0.180 |
Why?
| | Carboxylic Acids | 2 | 2019 | 31 | 0.180 |
Why?
| | Oligonucleotides | 3 | 2018 | 153 | 0.180 |
Why?
| | Protein Subunits | 2 | 2015 | 229 | 0.180 |
Why?
| | Phenylalanine | 1 | 2022 | 69 | 0.180 |
Why?
| | Histone Code | 1 | 2022 | 39 | 0.180 |
Why?
| | Proteolysis | 3 | 2017 | 172 | 0.180 |
Why?
| | Viral Core Proteins | 2 | 2012 | 21 | 0.180 |
Why?
| | Drug Discovery | 3 | 2019 | 153 | 0.170 |
Why?
| | Cyclophilin A | 2 | 2024 | 27 | 0.170 |
Why?
| | Glycine | 1 | 2022 | 186 | 0.170 |
Why?
| | HTLV-I Infections | 4 | 2019 | 29 | 0.170 |
Why?
| | Peroxidases | 2 | 1999 | 28 | 0.170 |
Why?
| | RNA | 1 | 2008 | 910 | 0.170 |
Why?
| | Reverse Transcription | 1 | 2021 | 20 | 0.170 |
Why?
| | Lentiviruses, Primate | 1 | 2021 | 12 | 0.170 |
Why?
| | Isoenzymes | 3 | 1999 | 294 | 0.170 |
Why?
| | Purines | 1 | 2002 | 187 | 0.160 |
Why?
| | Deuterium Exchange Measurement | 1 | 2020 | 26 | 0.160 |
Why?
| | Chromatin | 2 | 2022 | 553 | 0.160 |
Why?
| | Tea | 2 | 1997 | 17 | 0.160 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 53 | 0.160 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 820 | 0.160 |
Why?
| | Manganese | 2 | 1999 | 55 | 0.160 |
Why?
| | Cross-Linking Reagents | 2 | 2016 | 206 | 0.160 |
Why?
| | Base Sequence | 7 | 2016 | 2170 | 0.160 |
Why?
| | Necrosis | 1 | 2021 | 244 | 0.160 |
Why?
| | Retroviridae Proteins | 2 | 2017 | 10 | 0.150 |
Why?
| | Reverse Transcriptase Inhibitors | 2 | 2011 | 87 | 0.150 |
Why?
| | Amino Acid Substitution | 2 | 2013 | 302 | 0.150 |
Why?
| | Neuroblastoma | 1 | 2021 | 174 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2013 | 425 | 0.150 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2000 | 414 | 0.150 |
Why?
| | Stereoisomerism | 1 | 2019 | 103 | 0.150 |
Why?
| | Animals | 13 | 2025 | 38030 | 0.140 |
Why?
| | Protein Interaction Mapping | 3 | 2012 | 105 | 0.140 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 48 | 0.140 |
Why?
| | Gene Products, vpr | 1 | 2018 | 2 | 0.140 |
Why?
| | Amino Acids | 1 | 2022 | 519 | 0.140 |
Why?
| | Glycerol | 1 | 2018 | 90 | 0.140 |
Why?
| | Substrate Specificity | 4 | 2016 | 387 | 0.130 |
Why?
| | Protein Folding | 2 | 2016 | 276 | 0.130 |
Why?
| | Surface Plasmon Resonance | 1 | 2017 | 87 | 0.130 |
Why?
| | Immunoblotting | 2 | 2016 | 295 | 0.130 |
Why?
| | High Mobility Group Proteins | 1 | 2017 | 45 | 0.130 |
Why?
| | Peroxidase | 1 | 1997 | 168 | 0.120 |
Why?
| | Transcriptional Elongation Factors | 1 | 2017 | 39 | 0.120 |
Why?
| | 5' Untranslated Regions | 2 | 2021 | 59 | 0.120 |
Why?
| | meta-Aminobenzoates | 1 | 2016 | 1 | 0.120 |
Why?
| | alpha-Defensins | 1 | 2016 | 11 | 0.120 |
Why?
| | Nucleocapsid | 1 | 2016 | 19 | 0.120 |
Why?
| | Adenosine | 1 | 2018 | 255 | 0.120 |
Why?
| | Protein Structure, Secondary | 3 | 2008 | 371 | 0.120 |
Why?
| | Mutant Proteins | 2 | 2014 | 105 | 0.120 |
Why?
| | DNA Packaging | 1 | 2016 | 24 | 0.120 |
Why?
| | Ribonuclease P | 1 | 2016 | 22 | 0.120 |
Why?
| | DNA, Single-Stranded | 3 | 2006 | 117 | 0.120 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 192 | 0.120 |
Why?
| | Dynamic Light Scattering | 1 | 2016 | 7 | 0.120 |
Why?
| | Nucleic Acids | 1 | 2016 | 70 | 0.120 |
Why?
| | Calcium | 2 | 2021 | 1190 | 0.110 |
Why?
| | Morphogenesis | 1 | 2016 | 172 | 0.110 |
Why?
| | Drug Design | 1 | 2016 | 175 | 0.110 |
Why?
| | NIH 3T3 Cells | 2 | 2013 | 146 | 0.110 |
Why?
| | Spectrometry, Fluorescence | 1 | 2016 | 165 | 0.110 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2005 | 387 | 0.110 |
Why?
| | Models, Chemical | 1 | 2016 | 250 | 0.110 |
Why?
| | DEAD-box RNA Helicases | 2 | 2016 | 83 | 0.110 |
Why?
| | Histidine | 1 | 2014 | 66 | 0.110 |
Why?
| | Biotinylation | 2 | 2006 | 37 | 0.110 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 364 | 0.100 |
Why?
| | Gene Knockout Techniques | 1 | 2014 | 119 | 0.100 |
Why?
| | Escherichia coli | 4 | 2007 | 835 | 0.100 |
Why?
| | Hepatitis C | 1 | 2016 | 256 | 0.100 |
Why?
| | Circular Dichroism | 2 | 2012 | 151 | 0.100 |
Why?
| | Peptide Mapping | 2 | 2007 | 62 | 0.100 |
Why?
| | Nucleoproteins | 2 | 2017 | 38 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2017 | 728 | 0.100 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2014 | 530 | 0.100 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 139 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 440 | 0.100 |
Why?
| | Hydrolysis | 3 | 2007 | 197 | 0.100 |
Why?
| | Genetic Vectors | 1 | 2014 | 335 | 0.090 |
Why?
| | DNA Repair | 2 | 2009 | 254 | 0.090 |
Why?
| | Gene Expression Regulation, Viral | 3 | 2021 | 93 | 0.090 |
Why?
| | Thermodynamics | 3 | 2020 | 419 | 0.090 |
Why?
| | Human T-lymphotropic virus 2 | 1 | 2012 | 1 | 0.090 |
Why?
| | HTLV-II Infections | 1 | 2012 | 3 | 0.090 |
Why?
| | Azepines | 1 | 2013 | 105 | 0.090 |
Why?
| | Scattering, Small Angle | 1 | 2012 | 22 | 0.090 |
Why?
| | X-Ray Diffraction | 1 | 2012 | 83 | 0.090 |
Why?
| | Indoleacetic Acids | 1 | 2012 | 10 | 0.090 |
Why?
| | Calorimetry | 3 | 2001 | 69 | 0.090 |
Why?
| | Genetic Therapy | 1 | 2014 | 316 | 0.090 |
Why?
| | Triazoles | 1 | 2013 | 187 | 0.090 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 3542 | 0.090 |
Why?
| | Potassium Permanganate | 2 | 2002 | 3 | 0.090 |
Why?
| | RNA Interference | 1 | 2013 | 475 | 0.090 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2011 | 17 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 591 | 0.080 |
Why?
| | Virology | 1 | 2010 | 36 | 0.080 |
Why?
| | Kinetics | 4 | 2009 | 1567 | 0.080 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 179 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 155 | 0.080 |
Why?
| | DNA Polymerase beta | 1 | 2009 | 6 | 0.070 |
Why?
| | Ribonuclease H | 3 | 2007 | 12 | 0.070 |
Why?
| | Cloning, Molecular | 2 | 2000 | 538 | 0.070 |
Why?
| | Furans | 1 | 2008 | 26 | 0.070 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 321 | 0.070 |
Why?
| | Conserved Sequence | 2 | 2017 | 244 | 0.070 |
Why?
| | Models, Biological | 3 | 2019 | 1764 | 0.070 |
Why?
| | Urea | 1 | 2008 | 85 | 0.070 |
Why?
| | Autoantigens | 1 | 2011 | 427 | 0.070 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 452 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 441 | 0.070 |
Why?
| | Nuclear Lamina | 1 | 2007 | 12 | 0.070 |
Why?
| | Macromolecular Substances | 2 | 2010 | 216 | 0.060 |
Why?
| | Multiprotein Complexes | 2 | 2011 | 172 | 0.060 |
Why?
| | Phytic Acid | 1 | 2006 | 35 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2023 | 637 | 0.060 |
Why?
| | RNA Splicing | 2 | 2015 | 284 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 384 | 0.060 |
Why?
| | Ribonucleoproteins | 2 | 2020 | 89 | 0.060 |
Why?
| | Proteomics | 1 | 2013 | 1188 | 0.060 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2006 | 81 | 0.060 |
Why?
| | Electron Spin Resonance Spectroscopy | 3 | 1999 | 94 | 0.060 |
Why?
| | Phosphorylation | 3 | 2021 | 1707 | 0.050 |
Why?
| | Inhibitory Concentration 50 | 1 | 2004 | 90 | 0.050 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2004 | 9 | 0.050 |
Why?
| | Calreticulin | 1 | 2004 | 22 | 0.050 |
Why?
| | Viral Fusion Proteins | 1 | 2004 | 21 | 0.050 |
Why?
| | Avian Proteins | 1 | 2004 | 21 | 0.050 |
Why?
| | Carbohydrate Metabolism | 1 | 2004 | 59 | 0.050 |
Why?
| | Carbohydrates | 1 | 2004 | 66 | 0.050 |
Why?
| | Dimerization | 4 | 2007 | 189 | 0.050 |
Why?
| | Chickens | 1 | 2004 | 179 | 0.050 |
Why?
| | Glycosylation | 1 | 2004 | 173 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 1140 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 17 | 0.050 |
Why?
| | GTP Phosphohydrolases | 1 | 2024 | 93 | 0.050 |
Why?
| | Oxidation-Reduction | 2 | 1997 | 1067 | 0.050 |
Why?
| | Genes, Viral | 1 | 2023 | 88 | 0.050 |
Why?
| | Oxazines | 1 | 2023 | 37 | 0.050 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 2003 | 35 | 0.050 |
Why?
| | Thymine | 1 | 2003 | 16 | 0.050 |
Why?
| | Acetylation | 1 | 2004 | 259 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 166 | 0.050 |
Why?
| | DNA, Fungal | 1 | 2003 | 76 | 0.050 |
Why?
| | Retroelements | 1 | 2003 | 50 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2002 | 106 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 977 | 0.050 |
Why?
| | Base Pair Mismatch | 1 | 2002 | 10 | 0.050 |
Why?
| | Static Electricity | 1 | 2022 | 114 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2022 | 88 | 0.050 |
Why?
| | Pyrococcus | 1 | 2001 | 1 | 0.040 |
Why?
| | Mice | 4 | 2013 | 18329 | 0.040 |
Why?
| | Nucleocapsid Proteins | 1 | 2021 | 28 | 0.040 |
Why?
| | DNA Primers | 2 | 2000 | 505 | 0.040 |
Why?
| | Methylation | 1 | 2022 | 242 | 0.040 |
Why?
| | Fluorescence Polarization | 1 | 2001 | 24 | 0.040 |
Why?
| | Pyrococcus furiosus | 1 | 2001 | 3 | 0.040 |
Why?
| | Chromatography | 1 | 2001 | 27 | 0.040 |
Why?
| | Enzyme Stability | 2 | 1999 | 73 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2007 | 1164 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2004 | 693 | 0.040 |
Why?
| | Entropy | 1 | 2020 | 44 | 0.040 |
Why?
| | Genes, Archaeal | 1 | 2000 | 5 | 0.040 |
Why?
| | Candida albicans | 1 | 2000 | 61 | 0.040 |
Why?
| | DNA, Archaeal | 1 | 2000 | 18 | 0.040 |
Why?
| | Cations, Divalent | 1 | 1999 | 47 | 0.040 |
Why?
| | Dogs | 1 | 2021 | 458 | 0.040 |
Why?
| | Time Factors | 2 | 2001 | 7123 | 0.040 |
Why?
| | Phosphoglycerate Mutase | 1 | 1999 | 2 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2000 | 130 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2000 | 362 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 886 | 0.040 |
Why?
| | PDZ Domains | 1 | 2019 | 11 | 0.040 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 10 | 0.040 |
Why?
| | Sorting Nexins | 1 | 2019 | 12 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 2 | 2003 | 573 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2023 | 1246 | 0.040 |
Why?
| | G-Quadruplexes | 1 | 2018 | 23 | 0.040 |
Why?
| | Molecular Structure | 1 | 2019 | 486 | 0.030 |
Why?
| | Virus Internalization | 1 | 2018 | 65 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 611 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 333 | 0.030 |
Why?
| | Virulence | 1 | 2019 | 278 | 0.030 |
Why?
| | Ascorbate Peroxidases | 1 | 1997 | 2 | 0.030 |
Why?
| | Transfection | 2 | 2012 | 926 | 0.030 |
Why?
| | Salicylic Acid | 1 | 1997 | 10 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1997 | 81 | 0.030 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 39 | 0.030 |
Why?
| | Cricetulus | 1 | 2017 | 118 | 0.030 |
Why?
| | Point Mutation | 2 | 2009 | 240 | 0.030 |
Why?
| | Lipids | 1 | 2022 | 707 | 0.030 |
Why?
| | CHO Cells | 1 | 2017 | 169 | 0.030 |
Why?
| | Gene Products, rex | 1 | 2017 | 1 | 0.030 |
Why?
| | Molecular Weight | 1 | 1997 | 312 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 825 | 0.030 |
Why?
| | Chick Embryo | 1 | 2017 | 132 | 0.030 |
Why?
| | Nucleoside-Triphosphatase | 1 | 2016 | 13 | 0.030 |
Why?
| | Hot Temperature | 1 | 2000 | 396 | 0.030 |
Why?
| | Simian foamy virus | 1 | 2016 | 3 | 0.030 |
Why?
| | Cell Survival | 2 | 2011 | 1100 | 0.030 |
Why?
| | Plant Proteins | 1 | 1997 | 111 | 0.030 |
Why?
| | Potyvirus | 1 | 2016 | 3 | 0.030 |
Why?
| | beta-Defensins | 1 | 2016 | 22 | 0.030 |
Why?
| | Chemical Precipitation | 1 | 2016 | 39 | 0.030 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2016 | 15 | 0.030 |
Why?
| | Acyltransferases | 1 | 2017 | 78 | 0.030 |
Why?
| | DNA Viruses | 1 | 2016 | 23 | 0.030 |
Why?
| | Molecular Motor Proteins | 1 | 2016 | 37 | 0.030 |
Why?
| | Protein Unfolding | 1 | 2016 | 34 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 2016 | 128 | 0.030 |
Why?
| | Protein Stability | 1 | 2016 | 176 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2016 | 141 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 192 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2021 | 2524 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2018 | 627 | 0.030 |
Why?
| | DNA Helicases | 1 | 2016 | 136 | 0.030 |
Why?
| | Arginine | 2 | 2007 | 264 | 0.030 |
Why?
| | Introns | 1 | 2015 | 255 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 5216 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1356 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 762 | 0.030 |
Why?
| | CpG Islands | 1 | 2014 | 163 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2014 | 190 | 0.020 |
Why?
| | Genetic Variation | 1 | 2018 | 972 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2012 | 23 | 0.020 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2012 | 5 | 0.020 |
Why?
| | Rats | 1 | 2021 | 5584 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 2012 | 80 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2440 | 0.020 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2012 | 25 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2015 | 572 | 0.020 |
Why?
| | Mice, Knockout | 2 | 2012 | 3124 | 0.020 |
Why?
| | Phenotype | 1 | 2020 | 3155 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 666 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 345 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1852 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 777 | 0.020 |
Why?
| | G2 Phase | 1 | 2011 | 39 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2011 | 115 | 0.020 |
Why?
| | Hydroxyl Radical | 1 | 2011 | 86 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2010 | 54 | 0.020 |
Why?
| | Cell Division | 1 | 2011 | 756 | 0.020 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2008 | 17 | 0.020 |
Why?
| | Nucleotides | 1 | 2009 | 129 | 0.020 |
Why?
| | Lamin Type A | 1 | 2007 | 49 | 0.020 |
Why?
| | Fibroblasts | 1 | 2012 | 1025 | 0.020 |
Why?
| | Tritium | 1 | 2006 | 67 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2006 | 14 | 0.020 |
Why?
| | Schiff Bases | 1 | 2006 | 7 | 0.020 |
Why?
| | 5-Hydroxytryptophan | 1 | 2006 | 19 | 0.020 |
Why?
| | Solutions | 1 | 2006 | 159 | 0.010 |
Why?
| | Palmitic Acids | 1 | 2005 | 10 | 0.010 |
Why?
| | Chymotrypsin | 1 | 2005 | 23 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 2005 | 73 | 0.010 |
Why?
| | Replication Protein A | 1 | 2005 | 14 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2005 | 234 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2005 | 319 | 0.010 |
Why?
| | Plasmids | 1 | 2005 | 373 | 0.010 |
Why?
| | Tryptophan | 1 | 2005 | 182 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 408 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2005 | 382 | 0.010 |
Why?
| | RNA, Fungal | 1 | 2003 | 67 | 0.010 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2003 | 90 | 0.010 |
Why?
| | Fluorometry | 1 | 2001 | 19 | 0.010 |
Why?
| | Carbocyanines | 1 | 2001 | 37 | 0.010 |
Why?
| | Fluorescein | 1 | 2001 | 24 | 0.010 |
Why?
| | Cell Membrane | 1 | 2005 | 707 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 48 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2001 | 88 | 0.010 |
Why?
| | Stem Cells | 1 | 2005 | 628 | 0.010 |
Why?
| | Enzyme Reactivators | 1 | 1999 | 2 | 0.010 |
Why?
| | Phanerochaete | 1 | 1999 | 3 | 0.010 |
Why?
| | Spectrophotometry | 1 | 1999 | 58 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 333 | 0.010 |
Why?
| | Vanadates | 1 | 1999 | 17 | 0.010 |
Why?
| | Escherichia coli Proteins | 1 | 2001 | 201 | 0.010 |
Why?
| | RNA Stability | 1 | 2000 | 107 | 0.010 |
Why?
| | Heme | 1 | 1999 | 89 | 0.010 |
Why?
| | Genes, Bacterial | 1 | 1999 | 152 | 0.010 |
Why?
| | Ligands | 1 | 2000 | 665 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1999 | 531 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2000 | 263 | 0.010 |
Why?
| | Temperature | 1 | 1999 | 633 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2001 | 967 | 0.010 |
Why?
| | Gene Expression | 1 | 1999 | 1476 | 0.010 |
Why?
|
|
Kvaratskhelia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|